cocktail
FDA Authorizes REGEN-COV for Post-Exposure Prophylaxis for COVID-19
The FDA revised the EUA for casirivimab and imdevimab, the Regeneron cocktail for post-exposure prophylaxis (PEP) ...
AUGUST 3, 2021
FDA Authorizes MAB Cocktail for Treatment of COVID-19
Casirivimab and imdevimab should be administered together for the treatment of mild to moderate COVID-19 patients ...
NOVEMBER 24, 2020
Load more